The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127413101 12741310 1 I 20110730 20160914 20160914 EXP US-ROCHE-795124 ROCHE 72.00 YR M Y 100.90000 KG 20160914 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127413101 12741310 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) 15MG/KG IV OVER 60 MINUTES ON DAY 1.?LAST DOSE PRIOR TO SERIOUS ADVERSE EVENT: 02/MAY/2011?COURSE:1 U 125085 1520 MG SOLUTION FOR INFUSION
127413101 12741310 2 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 2 U 125085 1520 MG
127413101 12741310 3 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSR 3 U 125085 1540 MG
127413101 12741310 4 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 5 U 125085 1560 MG
127413101 12741310 5 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 6 U 125085 1560 MG
127413101 12741310 6 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 8 U 125085 1560 MG
127413101 12741310 7 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 9 U 125085 1560 MG
127413101 12741310 8 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 10 U 125085 1520 MG
127413101 12741310 9 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 11 U 125085 1560 MG
127413101 12741310 10 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 12 U 125085 1560 MG
127413101 12741310 11 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 14 U 125085 1510 MG
127413101 12741310 12 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 15 U 125085 1470 MG
127413101 12741310 13 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 16 U 125085 1470 MG
127413101 12741310 14 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 17 U 125085 1470 MG
127413101 12741310 15 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 18 U 125085 1470 MG
127413101 12741310 16 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 19 U 125085 1470 MG
127413101 12741310 17 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 20 U 125085 1440 MG
127413101 12741310 18 SS LENALIDOMIDE LENALIDOMIDE 1 Oral 25MG PO QD ON DAYS 1-14?LAST DOSE PRIOR TO SERIOUS ADVERSE EVENT: 10/MAY/2011?COURSE 1 U 0 350 MG
127413101 12741310 19 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COUSE 2 U 0 350 MG
127413101 12741310 20 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 3 U 0 350 MG
127413101 12741310 21 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 5 U 0 350 MG
127413101 12741310 22 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 6 U 0 350 MG
127413101 12741310 23 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 8 U 0 350 MG
127413101 12741310 24 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 9 U 0 350 MG
127413101 12741310 25 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 10 U 0 350 MG
127413101 12741310 26 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 11 U 0 350 MG
127413101 12741310 27 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 12 U 0 225 MG
127413101 12741310 28 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 14 U 0 165 MG
127413101 12741310 29 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 15 U 0 210 MG
127413101 12741310 30 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 16 U 0 210 MG
127413101 12741310 31 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 17 U 0 210 MG
127413101 12741310 32 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 18 U 0 210 MG
127413101 12741310 33 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 19 U 0 120 MG
127413101 12741310 34 SS LENALIDOMIDE LENALIDOMIDE 1 Oral COURSE 20 U 0 80 MG
127413101 12741310 35 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE1 U 0 162 MG
127413101 12741310 36 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 2 U 0 162 MG
127413101 12741310 37 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COUSE 3 U 0 163 MG
127413101 12741310 38 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 5 U 0 164 MG
127413101 12741310 39 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 6 U 0 164 MG
127413101 12741310 40 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 8 U 0 164 MG
127413101 12741310 41 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 9 U 0 164 MG
127413101 12741310 42 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 10 U 0 164 MG
127413101 12741310 43 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 11 U 0 164 MG
127413101 12741310 44 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 12 U 0 164 MG
127413101 12741310 45 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 14 U 0 158 MG
127413101 12741310 46 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 15 U 0
127413101 12741310 47 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 16 U 0 155 MG
127413101 12741310 48 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 17 U 0 155 MG
127413101 12741310 49 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 18 U 0 155 MG
127413101 12741310 50 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COURSE 19 U 0 155 MG
127413101 12741310 51 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) COUSE 20 U 0 154 MG
127413101 12741310 52 SS PREDNISONE. PREDNISONE 1 Oral COURSE:1 U 0 195 MG
127413101 12741310 53 SS PREDNISONE. PREDNISONE 1 Oral COURSE 2 U 0 200 MG
127413101 12741310 54 SS PREDNISONE. PREDNISONE 1 Oral COURSE 3 U 0 210 MG
127413101 12741310 55 SS PREDNISONE. PREDNISONE 1 Oral COURSE 5 U 0 220 MG
127413101 12741310 56 SS PREDNISONE. PREDNISONE 1 Oral COURSE 6 U 0 220 MG
127413101 12741310 57 SS PREDNISONE. PREDNISONE 1 Oral COURSE 8 U 0 170 MG
127413101 12741310 58 SS PREDNISONE. PREDNISONE 1 Oral COURSE 9 U 0 205 MG
127413101 12741310 59 SS PREDNISONE. PREDNISONE 1 Oral COURSE 10 U 0 220 MG
127413101 12741310 60 SS PREDNISONE. PREDNISONE 1 Oral COURSE 11 U 0 200 MG
127413101 12741310 61 SS PREDNISONE. PREDNISONE 1 Oral COURSE 12 U 0 210 MG
127413101 12741310 62 SS PREDNISONE. PREDNISONE 1 Oral COURSE 14 U 0 220 MG
127413101 12741310 63 SS PREDNISONE. PREDNISONE 1 Oral COURSE 15 U 0 200 MG
127413101 12741310 64 SS PREDNISONE. PREDNISONE 1 Oral COURSE 16 U 0 210 MG
127413101 12741310 65 SS PREDNISONE. PREDNISONE 1 Oral COURSE 17 U 0 220 MG
127413101 12741310 66 SS PREDNISONE. PREDNISONE 1 Oral COURSE 18 U 0 210 MG
127413101 12741310 67 SS PREDNISONE. PREDNISONE 1 Oral COURSE 19 U 0 210 MG
127413101 12741310 68 SS PREDNISONE. PREDNISONE 1 Oral COURSE 20 U 0 210 MG
127413101 12741310 69 C LOVENOX ENOXAPARIN SODIUM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127413101 12741310 1 Prostate cancer
127413101 12741310 18 Prostate cancer
127413101 12741310 35 Prostate cancer
127413101 12741310 52 Prostate cancer

Outcome of event

Event ID CASEID OUTC COD
127413101 12741310 OT
127413101 12741310 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127413101 12741310 Anaemia
127413101 12741310 Hypophosphataemia
127413101 12741310 Neutrophil count decreased
127413101 12741310 Platelet count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127413101 12741310 35 20100914 0
127413101 12741310 36 20101004 0
127413101 12741310 37 20101025 0
127413101 12741310 38 20101206 0
127413101 12741310 39 20101227 0
127413101 12741310 40 20110207 0
127413101 12741310 41 20110228 0
127413101 12741310 42 20110321 0
127413101 12741310 43 20110412 0
127413101 12741310 44 20110502 0
127413101 12741310 45 20110613 0
127413101 12741310 46 20110705 0
127413101 12741310 47 20110725 0
127413101 12741310 48 20110815 0
127413101 12741310 49 20110906 0
127413101 12741310 50 20110927 0
127413101 12741310 51 20111018 0
127413101 12741310 52 20100914 0
127413101 12741310 53 20101004 0
127413101 12741310 55 20101206 0
127413101 12741310 56 20101227 0
127413101 12741310 58 20110228 0
127413101 12741310 59 20110321 0
127413101 12741310 60 20110412 0
127413101 12741310 61 20110502 0
127413101 12741310 62 20110613 0
127413101 12741310 63 20110705 0
127413101 12741310 64 20110725 0
127413101 12741310 65 20110815 0
127413101 12741310 66 20110906 0
127413101 12741310 67 20110927 0
127413101 12741310 68 20111018 0

Execution Time: 0.0061671733856201 seconds (ucode:5052095). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.